Horacio Salomón

4.8k total citations
128 papers, 3.5k citations indexed

About

Horacio Salomón is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Horacio Salomón has authored 128 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Virology, 85 papers in Infectious Diseases and 41 papers in Epidemiology. Recurrent topics in Horacio Salomón's work include HIV Research and Treatment (96 papers), HIV/AIDS drug development and treatment (76 papers) and HIV/AIDS Research and Interventions (50 papers). Horacio Salomón is often cited by papers focused on HIV Research and Treatment (96 papers), HIV/AIDS drug development and treatment (76 papers) and HIV/AIDS Research and Interventions (50 papers). Horacio Salomón collaborates with scholars based in Argentina, Canada and United States. Horacio Salomón's co-authors include Mark A. Wainberg, Zhengxian Gu, Gabriela Turk, Pedro Cahn, Michael A. Parniak, Sandra Pampuro, Natalia Laufer, J. M. Cameron, María Mercedes Ávila and Yudong Quan and has published in prestigious journals such as Science, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Horacio Salomón

126 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Horacio Salomón Argentina	31	2.4k	2.3k	893	525	476	128	3.5k
Ricardo Sobhie Diaz Brazil	30	1.9k 0.8×	2.0k 0.8×	672 0.8×	346 0.7×	292 0.6×	159	3.1k
Michael M. Thomson Spain	34	1.9k 0.8×	1.6k 0.7×	849 1.0×	497 0.9×	433 0.9×	88	2.9k
Miguel E. Quiñones‐Mateu United States	34	2.5k 1.0×	2.4k 1.0×	784 0.9×	707 1.3×	568 1.2×	110	3.7k
Béda Joos Switzerland	37	2.3k 0.9×	1.8k 0.8×	709 0.8×	641 1.2×	701 1.5×	65	3.4k
Bluma Brenner Canada	37	4.1k 1.7×	4.2k 1.8×	1.1k 1.2×	676 1.3×	354 0.7×	143	5.0k
Margaret Tisdale United Kingdom	33	2.4k 1.0×	2.8k 1.2×	1.3k 1.4×	1.0k 1.9×	213 0.4×	64	4.1k
Salvatore T. Butera United States	29	1.9k 0.8×	1.2k 0.5×	782 0.9×	588 1.1×	975 2.0×	58	2.8k
Michael S Saag United States	13	2.6k 1.0×	2.5k 1.1×	1.1k 1.3×	345 0.7×	780 1.6×	24	3.8k
Georgios Pollakis Netherlands	29	1.7k 0.7×	1.1k 0.5×	785 0.9×	685 1.3×	920 1.9×	95	2.9k
Chris Verhofstede Belgium	31	1.9k 0.8×	1.8k 0.8×	600 0.7×	260 0.5×	285 0.6×	101	2.7k

Countries citing papers authored by Horacio Salomón

Since Specialization

Citations

This map shows the geographic impact of Horacio Salomón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Horacio Salomón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Horacio Salomón more than expected).

Fields of papers citing papers by Horacio Salomón

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Horacio Salomón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Horacio Salomón. The network helps show where Horacio Salomón may publish in the future.

Co-authorship network of co-authors of Horacio Salomón

This figure shows the co-authorship network connecting the top 25 collaborators of Horacio Salomón. A scholar is included among the top collaborators of Horacio Salomón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Horacio Salomón. Horacio Salomón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Laufer, Natalia, María Belén Bouzas, Horacio Salomón, et al.. (2024). Pretreatment HIV-1 Resistance in Argentina: Results from the Second Surveillance Study Following World Health Organization Guidelines (2019). AIDS Research and Human Retroviruses. 40(8). 464–470. 1 indexed citations

Ghiglione, Yanina, Ajantha Rhodes, María Florencia Quiroga, et al.. (2020). Hepatitis C Virus (HCV) Clearance After Treatment With Direct-Acting Antivirals in Human Immunodeficiency Virus (HIV)-HCV Coinfection Modulates Systemic Immune Activation and HIV Transcription on Antiretroviral Therapy. Open Forum Infectious Diseases. 7(5). 8 indexed citations

Sued, Omar, Yanina Ghiglione, María A. Pando, et al.. (2018). Computational comparison of availability in CTL/gag epitopes among patients with acute and chronic HIV-1 infection. Vaccine. 36(28). 4142–4151. 1 indexed citations

Ghiglione, Yanina, Juliana Falivene, M. Eugenia Socías, et al.. (2014). HIV-1 Env-specific IgA/IgG Ratio Is Related to Antibody Dependent Cellular Cytotoxicity (ADCC) Responses Observed during Acute/Early HIV Infection. AIDS Research and Human Retroviruses. 30(S1). A89–A89. 1 indexed citations

Jurado, Javier O., Virginia Pasquinelli, Ivana B. Alvarez, et al.. (2012). ICOS, SLAM and PD‐1 expression and regulation on T lymphocytes reflect the immune dysregulation in patients with HIV‐related illness with pulmonary tuberculosis. Journal of the International AIDS Society. 15(2). 17428–17428. 11 indexed citations

Jones, Leandro R., et al.. (2011). Drug Resistance Mutations in HIV pol Sequences from Argentinean Patients Under Antiretroviral Treatment: Subtype, Gender, and Age Issues. AIDS Research and Human Retroviruses. 28(8). 949–955. 4 indexed citations

Sued, Omar, María Florencia Quiroga, M. Eugenia Socías, et al.. (2011). Acute HIV Seroconversion Presenting with Active Tuberculosis and Associated with High Levels of T-Regulatory Cells. Viral Immunology. 24(4). 347–349. 2 indexed citations

Pando, María A., Andrea Rubio, Diana Rossi, et al.. (2010). Incidence of HIV Type 1 Infection, Antiretroviral Drug Resistance, and Molecular Characterization in Newly Diagnosed Individuals in Argentina: A Global Fund Project. AIDS Research and Human Retroviruses. 27(1). 17–23. 35 indexed citations

Dilernia, Darío, Leandro R. Jones, María A. Pando, et al.. (2010). Analysis of HIV Type 1 BF Recombinant Sequences from South America Dates the Origin of CRF12_BF to a Recombination Event in the 1970s. AIDS Research and Human Retroviruses. 27(5). 569–578. 10 indexed citations

10.

Turk, Gabriela, et al.. (2009). Single Nef Proteins from HIV Type 1 Subtypes C and F Fail to Upregulate Invariant Chain Cell Surface Expression But Are Active for Other Functions. AIDS Research and Human Retroviruses. 25(3). 285–296. 9 indexed citations

11.

Quarleri, Jorge, María Belén Bouzas, Natalia Laufer, et al.. (2007). Hepatitis B Virus Genotype Distribution and Its Lamivudine-Resistant Mutants in HIV-Coinfected Patients with Chronic and Occult Hepatitis B. AIDS Research and Human Retroviruses. 23(4). 525–531. 34 indexed citations

12.

Dilernia, Darío, et al.. (2007). HIV Type 1 Genetic Diversity Surveillance among Newly Diagnosed Individuals from 2003 to 2005 in Buenos Aires, Argentina. AIDS Research and Human Retroviruses. 23(10). 1201–1207. 34 indexed citations

13.

Salomón, Horacio, et al.. (2006). HIV-1 Infection Downregulates Nuclear Telomerase Activity on Lymphoblastoic Cells Without Affecting the Enzymatic Components at the Transcriptional Level. AIDS Research and Human Retroviruses. 22(5). 425–429. 15 indexed citations

14.

Quarleri, Jorge, Andrea Rubio, Mauricio Carobene, et al.. (2004). HIV Type 1 BF Recombinant Strains Exhibit Different pol Gene Mosaic Patterns: Descriptive Analysis from 284 Patients under Treatment Failure. AIDS Research and Human Retroviruses. 20(10). 1100–1107. 43 indexed citations

15.

Zala, Carlos, et al.. (2003). Discrepant results in the interpretation of HIV‐1 drug‐resistance genotypic data among widely used algorithms. HIV Medicine. 4(1). 72–78. 45 indexed citations

16.

Borkow, Gadi, Horacio Salomón, Mark A. Wainberg, & Michael A. Parniak. (2002). Attenuated Infectivity of HIV Type 1 from Epithelial Cells Pretreated with a Tight-Binding Nonnucleoside Reverse Transcriptase Inhibitor. AIDS Research and Human Retroviruses. 18(10). 711–714. 20 indexed citations

17.

Mansour, Tarek S., Haolun Jin, Wei Wang, et al.. (1995). Structure-Activity Relationships Among a New Class of Antiviral Heterosubstituted 2′,3′-Dideoxynucleoside Analogues. Nucleosides and Nucleotides. 14(3-5). 627–635. 18 indexed citations

18.

Anazodo, Michael, Horacio Salomón, Albert D. Friesen, M A Wainberg, & James R. Wright. (1995). Antiviral activity and protection of cells against human immunodeficiency virus type-1 using an antisense oligodeoxyribonucleotide phosphorothioate complementary to the 5′-LTR region of the viral genome. Gene. 166(2). 227–232. 8 indexed citations

19.

Quarleri, Jorge, María Belén Bouzas, Natalia Laufer, et al.. (1993). HCV genotype distribution among HIV co-infected individuals in Argentina: relationship with host and viral factors.. TLS, the Times literary supplement/Times literary supplement on CD-ROM/TLS. Times literary supplement. 37(2). 10–83. 16 indexed citations

20.

Carballal, Guadalupe, et al.. (1990). Etiologic and Clinical Evaluation of Acute Lower RespiratoryThact Infections in Young Argentinian Children: An Overview. Clinical Infectious Diseases. 12(Supplement_8). S889–S898. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact